Table of contents
Mounjaro helps with weight loss, but what happens to the body when treatment continues for months or years? Weight loss is only part of the story. Drug tolerance, diet, maintaining muscle mass and the changes you can see in the mirror are also important.
Mounjaro includes thirzepatide, a substance used to treat type 2 diabetes and to manage body weight in people who meet specific medical criteria. The medicine helps regulate appetite and blood glucose levels, and leads to significant weight loss in many patients.
Is long-term use of Mounjaro safe? What side effects might occur during treatment? And why do some patients notice a change in the contours of their face, sagging skin or increased hair loss?
To answer this, we need to distinguish between two things: the direct side effects of the medicine and the changes resulting from the weight-loss process itself. They are not the same thing.
The long-term effects of using Mounjaro – what do we know about its safety?
Mounjaro treatment It may offer significant health benefits, but requires appropriate assessment and medical supervision. Not every patient responds to the medicine in the same way. These differences relate to both the effectiveness of the treatment and the tolerance of individual doses.
The available research confirms the efficacy of tirzepatide in controlling blood glucose levels and reducing body weight in the patient groups studied. However, this does not mean that all possible consequences of long-term use of the medicine are already known. Safety data are still being collected and analysed.
In practice, during long-term treatment, attention should be paid to:
- tolerance to the medicine and any gastrointestinal symptoms;
- the rate of weight loss and the ability to maintain a balanced diet;
- hydration and the risk of complications associated with severe vomiting or diarrhoea;
- glucose levels, particularly when used in combination with other antidiabetic medicines;
- changes in body composition, skin condition and hair condition.
There is no basis for assuming that every patient who uses Mounjaro over a prolonged period will suffer permanent damage to their health. Nor can it be guaranteed in advance that the treatment will be risk-free.
Safety is determined by the indications for treatment, the patient’s state of health, the medicines they are taking and the way the treatment is administered.

What side effects might occur with long-term use of Mounjaro?
Most frequently reported side effects of tirzepatide relate to the digestive system. These include nausea, diarrhoea, constipation, vomiting and abdominal pain. These symptoms may be particularly noticeable at the start of treatment and following a dose increase.
In many patients, these symptoms are mild or moderate in severity and subside over time. However, symptoms that persist, worsen or interfere with normal functioning should not be ignored.
Can Mounjaro lead to dehydration?
This risk arises primarily when nausea, vomiting or diarrhoea make it difficult to take in fluids. Severe dehydration can, in turn, impair kidney function, particularly in people with pre-existing health conditions.
If you are unable to keep fluids down, are noticeably urinating less, or are experiencing severe weakness and dizziness, contact your doctor urgently.
Could Mounjaro increase the risk of pancreatitis?
Pancreatitis is one of the serious complications requiring attention during treatment with tirzepatide. Severe, persistent abdominal pain, particularly if it radiates to the back, requires urgent medical assessment. If pancreatitis is suspected, seek medical help immediately and do not take the next dose until you have received urgent medical advice.
Similarly, one should respond to symptoms that may indicate problems with the gallbladder, such as severe pain in the upper right side of the abdomen, particularly if accompanied by a fever or yellowing of the skin. Rapid weight loss in itself may also increase the risk of gallstones.
What about hypoglycaemia?
The risk of over- low blood glucose levels This is particularly important for people who are also taking insulin or sulphonylureas. In such cases, your doctor may need to adjust your treatment and recommend more frequent blood glucose monitoring.
A full list of side effects and precautions can be found in the official the Mounjaro documentation from the European Medicines Agency.
Mounjaro and facial appearance. What causes the loss of volume?
Not every effect of treatment is visible in test results. Sometimes the first change a patient notices is The face after Mounjaro treatment.
The cheeks become less full. The nasolabial folds appear deeper. The temples may look sunken, and the jawline becomes less defined. Some people also feel that their face looks more tired than it did before they started losing weight.
Such changes are sometimes referred to as „Mounjaro face”. It is not an official medical condition, nor is it a distinct adverse reaction confirming that the medicine directly damages the skin.
This is most often due to the effects of losing body fat.
During weight reduction Subcutaneous fat reserves, which give the face its volume and support its natural proportions, also decrease. If the loss is significant, the change may become visible around the cheeks, temples and under the eyes.
This does not mean that Mounjaro directly destroys collagen or accelerates the ageing of the skin. The appearance of the face depends on many factors: age, genetics, the initial condition of the skin, the amount of weight lost and the rate of weight loss.

Why doesn’t the skin always keep pace with weight loss?
The skin has the ability to gradually adapt to changes in body volume. However, it does not always do so to the extent we might expect.
As we get older, collagen production decreases and elastins, i.e. proteins responsible, amongst other things, for the skin’s elasticity and firmness. Following significant weight loss, therefore, increased sagging may become apparent, particularly on the neck, chin, cheeks and arms.
This is an important distinction: Loss of volume and loss of skin firmness are two different problems. They may occur at the same time, but do not always require the same course of action.
Does long-term use of Mounjaro cause hair loss?
Increased hair loss It may occur during a period of intensive weight loss. However, it should not automatically be attributed to the direct effects of tirzepatide.
One possible explanation is telogen effluvium. This is a type of temporary hair loss that can occur following significant physical stress, including rapid weight loss.
Nutritional deficiencies may also play a role. If, as a result of a reduced appetite, a patient is not consuming enough calories, protein, iron or other nutrients, the condition of their hair may deteriorate.
What’s worth doing?
- Pay attention to your protein intake and the overall nutritional value of your diet.
- Discuss persistent or worsening hair loss with your doctor.
- Where indicated, carry out laboratory tests appropriate to the patient’s symptoms and medical history.
- Do not start taking iron supplements or high doses of vitamins without first checking for any possible deficiencies.
Hair loss can have many causes, which is why a proper diagnosis is more important than simply looking for a hair growth treatment on your own.
Mounjaro and malnutrition and muscle loss
A reduced appetite It helps to limit the amount of food consumed. However, it may make it difficult to provide the body with all the nutrients it needs.
In the case of a significant weight reduction it is not only decreasing body fat percentage. Some loss of lean body mass, including muscle, may also occur. The extent of this loss depends, amongst other things, on the extent of the weight loss, diet and physical activity.
If a patient eats very little, avoids protein-rich foods and does not exercise, they may gradually lose strength and fitness. This is a problem that should not be assessed solely on the basis of the number of kilograms on the scales.
During treatment, it is worth ensuring that:
- an adequate supply of energy and protein, tailored to individual needs;
- regular meals, even if your appetite is reduced;
- resistance training tailored to your health and abilities;
- adequate hydration;
- a dietary consultation, if restricting food intake makes it difficult to meet nutritional requirements.
There is no single, universal amount of protein that is suitable for everyone. In cases of kidney disease or other chronic conditions, dietary recommendations should be determined on an individual basis.

Can Mounjaro be used for several years?
Long-term treatment with Mounjaro This may be justified if the patient continues to meet the criteria for treatment, is benefiting from it and tolerates it well. The duration of treatment should be based on a medical assessment, rather than on a self-imposed limit in terms of months.
Obesity is a chronic condition. For this reason, treatment may require a long-term plan that encompasses not only medication but also diet, physical activity and health monitoring.
During subsequent visits, the doctor assesses the effectiveness of the treatment, the patient’s tolerance of the medication and whether any changes to the treatment plan are required. The scope of the tests depends on the indication for treatment, any underlying conditions, the medication being taken and the symptoms reported.
You should not increase or decrease the dose, change the dosing regimen or stop taking the medicine simply because your weight has stopped falling rapidly.
What happens after you stop taking Mounjaro?
Stopping Mounjaro treatment This does not mean that maintaining the weight you have achieved will be as easy as it was whilst taking the medicine.
Once the medication is stopped, your appetite may return, and with it, difficulty in maintaining your current weight. Some people experience weight regain. The extent of these changes varies from person to person and depends, amongst other things, on the body’s biological response and subsequent management.
Therefore decision to discontinue treatment This should be discussed with your doctor. It is a good idea to draw up a plan in advance for monitoring your weight, diet and physical activity.
If changes in facial appearance or skin laxity have also occurred during treatment, their assessment forms a separate part of the management plan. Simply discontinuing the medication does not guarantee the restoration of lost volume or skin firmness.
How can you prevent your appearance from changing for the worse whilst losing weight?
Not every change can be prevented. However, you can take steps to ensure that the factors which support the body during weight loss are in place.
1. Don’t focus solely on the number on the scales
The rate of weight loss should be tailored to your state of health and the course of your treatment. If you lose weight very quickly and this is accompanied by significant weakness, difficulty eating or other worrying symptoms, you should discuss the situation with your doctor.
2. Look after your skin, but don’t expect cosmetics to do everything
Regular moisturising, restoring the skin’s protective barrier and daily sun protection help to keep the skin in good condition. However, they cannot replace lost tissue volume, nor are they always sufficient in cases of significant sagging.
3. Stay physically active
A carefully tailored resistance training programme helps to maintain muscle mass whilst losing weight. An exercise programme should take into account age, fitness level, any underlying medical conditions and your doctor’s advice.
4. Assess the results as a whole
Body weight is just one of the parameters. Muscle strength, general well-being, test results, nutritional status and tolerance to treatment are also important.
If any worrying symptoms appear, the first step is to identify their cause. Only then should you decide on any additional skincare or cosmetic treatments.

What treatments can help with skin laxity following Mounjaro?
If, following significant weight loss, your skin has lost its firmness, you may wish to seek advice on methods to improve its tone and texture.
Depending on the condition of your skin, your doctor may assess whether procedures such as the following are appropriate:
- Radiofrequency – utilises thermal energy to promote tissue regeneration and improve skin firmness.
- Laser therapy – depending on the type of laser, it can be used to improve skin texture, tone and certain signs of photoageing.
- Biostimulation treatments – certain treatments used in aesthetic medicine may stimulate tissue remodelling processes.
- Methods of volume restoration – In certain cases, a doctor may consider procedures to restore facial proportions.
There is no single treatment that is suitable for every patient. A method that works well for minor skin laxity will not necessarily be appropriate in cases of significant volume loss.
The stage of treatment, weight stability, state of health and the expected outcome are also important. Cosmetic procedures are no substitute for medical supervision and do not treat the side effects of the medication itself.
When should you contact your doctor urgently whilst taking Mounjaro?
Not every change in appearance poses a health risk. However, there are some symptoms that should not be ignored.
The following, amongst others, require urgent assessment:
- severe and persistent abdominal pain, particularly pain radiating to the back;
- persistent vomiting and signs of severe dehydration;
- severe abdominal pain accompanied by a fever or yellowing of the skin;
- swelling of the tongue or throat, or difficulty breathing;
- symptoms of severe hypoglycaemia, such as impaired consciousness.
If you experience breathing difficulties, lose consciousness or have any other symptoms that pose an immediate threat to life, you should call the emergency services.
However, excessive hair loss, difficulty maintaining a balanced diet, marked weakness or rapidly changing body weight require medical consultation, even if they are not accompanied by any alarming symptoms.
Do not change your Mounjaro dose yourself. If a serious adverse reaction is suspected, urgent medical assessment is required, along with a decision on further treatment.
Mounjaro and long-term health and appearance – what should you bear in mind?
Mounjaro It may be an effective part of the treatment of type 2 diabetes and weight management in suitably selected patients. Like any medicine, however, it is associated with certain side effects and requires appropriate monitoring.
Changes in appearance observed during weight loss are not always a direct result of tirzepatide. A loss of facial volume, sagging skin or increased hair loss may be linked to the rate of weight loss, changes in diet and individual physiological factors.
You should neither dismiss such symptoms nor automatically attribute them to the medicine. First, you need to identify the cause, and then choose the appropriate course of action tailored to the condition of your skin, the progress of your weight loss and the expected results.
Do you want to look after your figure and keep your skin in good condition whilst losing weight?
Losing weight isn’t everything. It’s just as important how your body copes with the whole weight-loss process and how the appearance of your skin, face and figure changes during that time. That’s why it’s worth ensuring you have the right support right from the planning stage of your weight-loss journey.
Body Genetic at Wellclinic This is a medical programme that combines diagnostics, medical care, individually tailored pharmacotherapy and technologies designed to support body contouring and improve skin firmness. Mounjaro or Ozempic may only be used following medical assessment. Would you like to find out if this approach is right for you? Discover the Body Genetic programme and explore the possibilities of personalised treatment.
Book a consultation at Wellclinic and discover the possibilities and discover treatment options tailored to your skin condition, your weight loss journey and your expected results.
Sources:
- PubMed „Tirzepatide Once Weekly for the Treatment of Obesity” https://pubmed.ncbi.nlm.nih.gov/35658024/
- PubMed „Once-Weekly Semaglutide in Adults with Overweight or Obesity” https://pubmed.ncbi.nlm.nih.gov/33567185/
- U.S. Food and Drug Administration (FDA) „Mounjaro (tirzepatide) Injection” https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
- U.S. Food and Drug Administration (FDA) „Ozempic (semaglutide) Injection” https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf
- PubMed „Telogen Effluvium: A Review” https://pubmed.ncbi.nlm.nih.gov/28686246/
- European Medicines Agency (EMA) „Mounjaro” https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro